The heme-regulated eIF2alpha kinase (HRI) phosphorylates the alpha subunit of the translation initiation factor 2, which plays an important role in translational regulation during heme deficiency. HRI is expressed mainly in erythroid cells. To elucidate the mechanisms that regulate the tissue-specific expression of the mouse HRI gene, we have cloned and characterized its 5' flanking region. Primer extension and 5' RACE analyses identified a major transcription initiation site 84 nucleotides upstream from the ATG start codon. Sequence analysis of the 5' flanking region revealed that HRI promoter lacked a TATA element, but contained an initiator core element and three SP1 consensus binding motifs. Transient transfection analysis using luciferase reporter gene constructs containing a series of deletions and mutations in the 5' region identified a 159 bp sequence which is necessary and sufficient for basal HRI promoter activities in NIH 3T3 and mouse erythroleukemic cells. Both the initiator and one of the SP1 binding sites in the 159 bp are essential for HRI promoter activity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0167-4781(01)00281-0 | DOI Listing |
Front Med (Lausanne)
March 2023
Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, Chile.
J Cell Mol Med
August 2021
Department of Human Molecular Genetics, Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.
Blood
June 2020
Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA.
Reactivation of fetal hemoglobin remains a critical goal in the treatment of patients with sickle cell disease and β-thalassemia. Previously, we discovered that silencing of the fetal γ-globin gene requires the erythroid-specific eIF2α kinase heme-regulated inhibitor (HRI), suggesting that HRI might present a pharmacologic target for raising fetal hemoglobin levels. Here, via a CRISPR-Cas9-guided loss-of-function screen in human erythroblasts, we identify transcription factor ATF4, a known HRI-regulated protein, as a novel γ-globin regulator.
View Article and Find Full Text PDFClin Cancer Res
December 2018
Department of Molecular Genetics and Oncode Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands.
Purpose: Tumors of germline mutated carriers show homologous recombination (HR) deficiency (HRD), resulting in impaired DNA double-strand break (DSB) repair and high sensitivity to PARP inhibitors. Although this therapy is expected to be effective beyond germline mutated carriers, a robust validated test to detect HRD tumors is lacking. In this study, we therefore evaluated a functional HR assay exploiting the formation of RAD51 foci in proliferating cells after irradiation of fresh breast cancer tissue: the recombination REpair CAPacity (RECAP) test.
View Article and Find Full Text PDFPlant Methods
May 2017
Department of Biological Sciences, Faculty of Science, King Abdulaziz University, P.O. Box 80141, Jeddah, 21589 Saudi Arabia.
Background: The main aim of this study was to improve fungal resistance in bread wheat via transgenesis. Transgenic wheat plants harboring barley () gene, driven by maize promoter, were obtained using biolistic bombardment, whereas the herbicide resistance gene, driven by the promoter was used as a selectable marker.
Results: Molecular analysis confirmed the integration, copy number, and the level of expression of the gene in four independent transgenic events.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!